About Rituxan
Rituxan is a Healthcare company. It develops and markets medications for oncology and immunology treatments. It operates on a B2B and D2C model. Its website rituxan.com draws about 11 thousand monthly visits. Rituxan offers products and services including RITUXAN. Its focus areas include Biopharmaceuticals, Oncology, Monoclonal Antibodies and Immunology. Its legal entity is Genentech, Inc.
Company details
Genentech is a biotechnology company that researches, develops, and manufactures biopharmaceutical products, including RITUXAN, a medication for treating non-Hodgkins lymphoma, chronic lymphocytic leukemia, rheumatoid arthritis, and other conditions. It operates by providing these drugs to healthcare professionals through prescriptions and clinical support. Based in South San Francisco, USA, Genentech focuses on innovative therapies and collaborates with medical institutions to ensure safe distribution and patient access.
Products & Services of Rituxan
Rituxan offers a comprehensive portfolio of products and services, including RITUXAN.
Treats cancers and autoimmune diseases through targeted therapy.
Apps and channels of Rituxan
its YouTube channel Roche has 20.8K subscribers and 30 videos.
Videos from Rituxan
The most watched videos on Rituxan's YouTube channel, Roche (20.8K subscribers). Click a video to play it here.
More on Roche.
Web traffic of Rituxan
The website of Rituxan (rituxan.com) receives about 10.8K visits a month and ranks #1,818,126 among all websites worldwide, #2,653 in Pharmacy.
- Monthly visits10.8K
▼ 23.7% vs previous month
- Unique visitors7.1K
per month
- Global rank#1,818,126
among all websites
- Category rank#2,653
Health · Pharmacy
- Bounce rate57%
- Pages per visit1.5
- Average visit32 sec
- DevicesDesktop 30% · Mobile 70%
Websites whose visitors overlap most with Rituxan. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| tysabri.com | 83% | 21.6K | #479,440 | View details | |
| cimzia.com | 74% | 14.8K | #1,906,947 | View details |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Rituxan
Complete news archive for Rituxan
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rituxan
Genentech is a biotechnology company that researches, develops, and manufactures biopharmaceutical products, including RITUXAN, a medication for treating non-Hodgkins lymphoma, chronic lymphocytic leukemia, rheumatoid arthritis, and other conditions. It operates by providing these drugs to healthcare professionals through prescriptions and clinical support. Based in South San Francisco, USA, Genentech focuses on innovative therapies and collaborates with medical institutions to ensure safe distribution and patient access.
Rituxan offers RITUXAN.
Rituxan operates through Genentech, Inc..